To test this hypothesis, the expression patterns of Cx36-positive plaques (structural assay) and the state of Cx36 phosphorylation (functional assay) in AII ACs in a mouse model of myopia were evaluated by using specific antibodies to the phosphorylated form of Cx36. The gene discussed is GJD2; the disease is myopia.